Fundz

Ensho Therapeutics reported raising $400,000 in an initial SEC Form D filing, from an offering of $2 Million

PRIVATEAug 06, 2024

Amount Raised

$400,000

$400,000 sold, per SEC Form D (first sale Jul 19, 2024)

Round Type

Venture

Woodcliff LakeBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharma

Who to call at Ensho Therapeutics, and when

A new round usually means Ensho Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Ensho Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Ensho Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Ensho Therapeutics. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Ensho Therapeutics

Location

Woodcliff Lake, New Jersey, United States

About

Ensho Therapeutics is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients with inflammatory diseases. The company launched with the announcement of acquiring a portfolio of oral α4β7 integrin inhibitors through a worldwide exclusive license agreement with EA Pharma Co., Ltd., a subsidiary of Eisai Co., Ltd. Ensho has the right to develop, manufacture, and commercialize these assets globally, excluding certain Asian jurisdictions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Ensho Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Ensho Therapeutics's next move

See what Strategic adds

Ensho Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.